Watch HealthMyne's CEO Rose Higgins interview with BioPharm America to see the value radiomics is bringing life sciences organizations. Learn how new novel radiomic data and AI is driving imaging biomarker discovery, enhancing clinical trials and delivering real world evidence of therapy response.
